GlassScriptPhysician profile
Nyrene Ahmed Haque
NPI 1891113866
$4,622.34
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,000 · 2020: $299 · 2021: $94.99 · 2022: $1,210 · 2023: $949 · 2024: $1,069.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,986 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,985.72 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,243.07 | 2019-2024 | Sogroya |
| Amryt Pharma Holdings LTD | $927.00 | 2022 | |
| Dexcom, INC. | $737.27 | 2022-2023 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Beta Bionics, INC. | $368.61 | 2024 | Ilet Bionic Pancreas |
| Amgen INC. | $362.04 | 2019-2024 | Evenity |
| Lilly USA, LLC | $268.31 | 2023-2024 | Mounjaro |
| Corcept Therapeutics | $245.27 | 2020-2024 | Korlym |
| Alexion Pharmaceuticals, INC. | $124.73 | 2024 | |
| Ascendis Pharma Endocrinology INC | $120.00 | 2023 | |
| Companion Medical, INC. | $95.59 | 2020 | |
| Chiasma, INC. | $94.99 | 2021 | |
| Medtronic Minimed, INC. | $35.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nyrene Haque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.